ArticleCancer biology & therapy2018

Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.